Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities.
Natsume A, In M, Takamura H, Nakagawa T, Shimizu Y, Kitajima K, Wakitani M, Ohta S, Satoh M, Shitara K, Niwa R.
Natsume A, et al. Among authors: shitara k.
Cancer Res. 2008 May 15;68(10):3863-72. doi: 10.1158/0008-5472.CAN-07-6297.
Cancer Res. 2008.
PMID: 18483271